Key result
Fetal echocardiography demonstrated a sensitivity of 82.5% and specificity of 96.7% for detecting congenital heart disease, with a 27% discrepant diagnosis rate compared to postnatal findings.
Why the study?
Data evaluating diagnostic errors of fetal echocardiography and their impact on planned neonatal management in lower- and middle-income countries were scarce.
Does fetal echocardiography accurately diagnose congenital heart disease and impact neonatal management in high-risk pregnancies?
Cohort (n=2,622)
No
Does fetal echocardiography accurately diagnose congenital heart disease and impact neonatal management in high-risk pregnancies?
Fetal echocardiography in a middle-income country demonstrates high specificity and acceptable sensitivity for detecting congenital heart disease, though discrepant diagnoses occur in about a quarter of cases, occasionally altering neonatal management.
Supports fetal echocardiography in high-risk pregnancies; leaves open prospective validation to reduce discrepancies and refine neonatal planning.
Introduction: Fetal echocardiogram allows early detection of critical congenital heart disease leading to a better outcome. However, data from lowerand middle-income countries is scarce. This study aims to evaluate the diagnostic error of fetal echocardiography and its impact on planned neonatal management. Methods and material: This retrospective observational cohort study includes all high-risk pregnant mothers who had fetal echocardiograms from 2008 to 2017. Fetal and postnatal echocardiograms were compared, while the diagnostic errors were categorized into false positive, false negative, and discrepant diagnoses. The impact of the diagnostic error on planned neonatal management and the long-term outcome was determined by comparing the outcome of expected and actual management. Results: A total of 2622 fetuses were included with the majority in the second half of the study. The mean gestational age of 2622 fetuses was 26.7 ± 3.42 weeks. Of 2622, 191 (7.3%) had congenital heart disease. Of 191, 130 (68%) were major lesions. Confirmatory postnatal echocardiogram was available in 153 fetuses with congenital heart disease and 905 fetuses with a normal heart. Of 1058, 123 were true positives, 30 were false positives, 26 were false negatives, and 879 were true negatives. Hence, the sensitivity, specificity, positive and negative likelihood ratio of fetal echocardiogram for detection of CHD in this study was 82.5% (95% confidence interval [CI]: 75.5% to 88.3%), 96.7% (95% CI: 95.3% to 97.8%), 25.0 (95% CI: 17.5 to 35.8) and 0.18 (95% CI: 0.13 to 0.26) respectively. Most of the false positives and negatives were mild lesions. There were 27% discrepant diagnosis between fetal and postnatal echocardiograms (8.1% partially different, and 18.7% no similarity), leading to 8.9% changes in planned neonatal management and 8.1% severity score. Most of the discrepant diagnoses were complex lesions. Conclusions: Despite relatively new services and limited resources, the diagnostic errors of fetal echocardiography in this study are comparable with centers in high-income countries. However, active participation of all stakeholders, changes in policy, and training are needed to improve fetal echocardiography services further. These are vital before the introduction of the national screening program.
No takes yet. Share an insight, caveat, or question.
Bah et al. (2020) conducted a cohort in High-risk pregnancy with suspected fetal congenital heart disease (n=2,622). Fetal echocardiography vs. Postnatal echocardiogram was evaluated on Sensitivity for detection of congenital heart disease (95% CI 75.5% to 88.3%). Fetal echocardiography demonstrated a sensitivity of 82.5% and specificity of 96.7% for detecting congenital heart disease, with a 27% discrepant diagnosis rate compared to postnatal findings.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: